π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
A phase II trial to compare the efficacy and safety of nivolumab and interm...
Status
Terminated
Location
Boris V Afanasyev, MD, Prof.
Start Date
2017-06-30
Trial ID
NCT03381118
Treatments Being Tested
Background: -DOCK8 deficiency is a genetic disorder that affects the immun...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2010-10-05
Trial ID
NCT01176006
This study will assess the feasibility of utilizing a reduced intensity con...
Status
Terminated
Location
Kenneth DeSantes., MD
Start Date
2008-08
Trial ID
NCT00582816
Treatments Being Tested
The MAC-HAPLO-MUD trial is a randomized prospective phase III trial compari...
Status
Unknown
Location
Multiple Locations
Start Date
2018-08
Trial ID
NCT03655145
Treatments Being Tested
This is a phase II trial of T cell receptor alpha/beta depletion (Ξ±/Ξ² TCD) ...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2018-11-13
Trial ID
NCT03579875
Background: Sickle cell disease (SCD) is a genetic disorder where red bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-12-28
Trial ID
NCT06145282
Treatments Being Tested